Amneal Pharmaceuticals, Inc. — Director's Dealing 2020

Aug 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amneal Pharmaceuticals, Inc. (AMRX)
CIK: 0001723128
Period of Report: 2020-08-02

Reporting Person: MEISTER PAUL M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-02	Class A Common Stock	M	27923	—	Acquired	27923	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-02	Restricted Stock Units	$	M	27923	Disposed		Class A Common Stock (27923)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2: On August 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on August 2, 2020.